How to use Semagard

Semagard dosage3

  • Your doctor will tell you how much Semagard to use to help control your blood sugar levels.
  • In adults over 18 years of age the general starting dose is 0,25 mg injected subcutaneously once-weekly for 4 weeks.
  • The starting dose helps your body get used to the Semagard and helps to limit the side effects.
  • After the first 4 weeks, your doctor will ask you to increase the once-weekly dose to 0,5 mg.
  • If after another month, your diabetes is not controlled on the 0,5 mg dose, your doctor may increase the dose to 1 mg once a week.

Getting started

SEMAGARD 0,25/0,5 mg pen

START

0,25 mg*

Once-weekly for first 4 weeks

STAY

0,5 mg

Once-weekly for at least 4 weeks

Use the pen that
delivers 0,25 or 0,5 mg only

* Semagard dose of 0,25 mg is not a therapeutic dose

Additional control

SEMAGARD 1 mg pen

1 mg

Once-weekly if additional blood sugar control is needed

Use the pen that
delivers 1 mg only

How to administer
semagard3

Semagard is administered as a subcutaneous injection once a week.​

Semagard can be administered at any time of the day.

The day of weekly administration can be changed if necessary, as long as the time between two doses is at least 2 days (> 48 hours)

Semagard can be taken with or without meals​

Semagard injection
sites:3,6

Subcutaneous means the injection is given in the fatty tissue just under the skin. Make sure the injection site has healthy skin (no redness, swelling, scarring, bruising or broken skin).

Disclaimer: This page provides general guidance on the use, storage, and safety of the product for the patients who have been prescribed this medicine by a registered medical practitioner. This shall neither be construed as a Promotional Activity nor constitute as medical advice. Since, this is solely for educational purposes, the contents hereof shall not be relied upon as a substitute for professional consultation. Anyone accessing this website shall be bound by these terms and the Company shall bear no responsibility or liability for any use of the product without a valid prescription or for any misuse arising from non adherence to prescribed instructions. Users must follow the directions provided in the Patient Information Leaflet and the advice of their treating Registered Medical Practitioner.

SIGN UP TO RECEIVE A WEEKLY
E-MAIL REMINDER TO TAKE
YOUR SEMAGARD INJECTION.

I WOULD LIKE TO RECEIVE MY REMINDER ON A:
S4 SEMAGARD (Solution for Injection). Reg. No.: 61/21.13/0768. Each 1 ml solution contains 1,34 mg of semaglutide. Preservative: phenol 5,50 mg/ml (0.55 % m/v). Contains propylene glycol 14 mg/ml. SEMAGARD 0,25 mg and 0,5 mg / dose pen: Each pre-filled pen contains 2 mg semaglutide in 1,5 ml solution. SEMAGARD 1 mg / dose pen: Each pre-filled pen contains 4 mg semaglutide in 3 ml solution.For full prescribing information, refer to the Professional Information approved by the Regulatory Authority.

Applicant: Ranbaxy Pharmaceuticals (Pty) Ltd., a Sun Pharma company. Reg. No. 1993/003111/07. 14 Lautre Road, Stormill Ext.1, Roodepoort, 1724. Tel: +27 11 495 0100. www.sunpharma.com. SEM/06-2026/06/Digital/KG